-
SECURE DEPLOYMENT OF LARGE LANGUAGE MODELS IN HEOR: GOVERNANCE, INFRASTRUCTURE, AND RISK MITIGATION BEST PRACTICES
Mar 18, 2026, 21:38 PM -
POWER, POLITICS, AND PRICE: GOVERNANCE FAILURES IN NEPAL’S PHARMACEUTICAL SYSTEM AND THE UHC CHALLENGE
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS AND REPORTING OF CLINICAL TRIAL EVIDENCE SUPPORTING THE APPROVAL OF CHINESE INNOVATIVE DRUGS (2018-2024): RETROSPECTIVE STUDY OF PUBLICATIONSAND NMPA REVIEW DOCUMENTS
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
INTEGRATING REAL-WORLD PHARMACOGENOMIC AND CLINICAL DATA USING MACHINE LEARNING TO IMPROVE DRUG RESPONSE PREDICTION: IMPLICATIONS FOR PRECISION MEDICINE DECISION MAKING
Mar 18, 2026, 21:38 PM -
AN INDIRECT TREATMENT COMPARISON (ITC) OF IFINATAMAB DERUXTECAN (I-DXD) VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY (RWPCT) IN PATIENTS PREVIOUSLY TREATED WITH AT LEAST 2 LINES OF THERAPY (LOTS) FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER...
Mar 18, 2026, 21:38 PM -
COST-UTILITY ANALYSIS OF [177LU]PSMA THERAPY COMPARED TO CABAZITAXEL IN PATIENTS WITH MCRPC FROM THE PERSPECTIVE OF THE COLOMBIAN HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
CONFIDENCE INTERVALS FOR EVENT-BASED NUMBER NEEDED TO TREAT: A PRACTICAL APPROACH FOR HEALTH ECONOMIC EVALUATION OUTPUTS
Mar 18, 2026, 21:38 PM -
REUSABLE DISCRETE-EVENT SIMULATION IN R: QUOSURE-BASED ENCAPSULATION OF SIMMER MODELS FOR SHINY REACTIVITY AND PARALLEL PROBABILISTIC SENSITIVITY ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF FIXED-DOSE SUBCUTANEOUS PERTUZUMAB-TRASTUZUMAB FOR NEOADJUVANT TREATMENT OF HIGH-RISK HER2-POSITIVE EARLY BREAST CANCER IN INDONESIA
Mar 18, 2026, 21:38 PM -
A REVIEW ON THE APPLICATION OF PATIENT-REPORTED OUTCOMES IN THE LABELING OF NEW ONCOLOGY DRUGS
Mar 18, 2026, 21:38 PM -
COST AND OUTCOMES OF INTEGRATING SEXUAL AND REPRODUCTIVE HEALTH SERVICES INTO HUMANITARIAN HEALTH PROGRAMS IN IDP CAMPS
Mar 18, 2026, 21:38 PM -
IMPROVING FOOD LITERACY AS AN EFFECTIVE METHOD OF HEALTH PROMOTION
Mar 18, 2026, 21:38 PM -
ASSESSING THE PSYCHOMETRIC PROPERTIES OF TWO INSTRUMENTS MEASURING ATTITUDES TOWARDS AI AND THEIR ASSOCIATED FACTORS
Mar 18, 2026, 21:38 PM -
BREAKING DOWN THE CITATION CHAIN IN HEALTH ECONOMIC MODELING: HOW FAR IS CURRENT PRACTICE FROM GUIDELINES (AND WHY GENAI MIGHT HELP)?
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW ON ECONOMIC EVALUATION OF LOW-DOSE ATROPINE FOR CHILDHOOD MYOPIA CONTROL: EVIDENCE FROM MODEL INSIGHTS
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A NOVEL ALGORITHM TO IDENTIFY CAPILLARY LEAK SYNDROME (CLS) IN US CLAIMS DATA
Mar 18, 2026, 21:38 PM -
STATIN INITIATION TIME AFTER GRAVES' DISEASE DIAGNOSIS AND THE RISK OF GRAVES' ORBITOPATHY: A ONE-YEAR LANDMARK ANALYSIS
Mar 18, 2026, 21:38 PM -
SUSTAINED FACTOR IX LEVELS AT 5-YEARS AFTER ETRANACOGENE DEZAPARVOVEC - THE EXPONENTIAL DECAY MODEL MAY UNDERESTIMATE OBSERVED RESULTS
Mar 18, 2026, 21:38 PM -
ECONOMIC OUTCOMES, REAL-WORLD ADHERENCE PATTERNS AND PREDICTIVE MODELING OF MIGRAINE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY OF TRIPTANS, BETA-BLOCKERS, AND COMBINATION THERAPY
Mar 18, 2026, 21:38 PM
